SB-253514 and analogues;: Novel inhibitors of lipoprotein associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579.: III.: Biotransformation using naringinase

被引:8
作者
Thirkettle, J [1 ]
机构
[1] SmithKline Beecham Pharmaceut, Worthing BN14 8QH, W Sussex, England
关键词
D O I
10.7164/antibiotics.53.733
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:733 / 735
页数:3
相关论文
共 8 条
[1]   SB-253514 and analogues:: Novel inhibitors of lipoprotein associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579 -: II.: Physico-chemical properties and structure elucidation [J].
Busby, DJ ;
Copley, RCB ;
Hueso, JA ;
Readshaw, SA ;
Rivera, A .
JOURNAL OF ANTIBIOTICS, 2000, 53 (07) :670-676
[2]   LYSOPHOSPHATIDYLCHOLINE INHIBITS RELAXATION OF RABBIT ABDOMINAL-AORTA MEDIATED BY ENDOTHELIUM-DERIVED NITRIC-OXIDE AND ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR-INDEPENDENT OF PROTEIN-KINASE-C ACTIVATION [J].
COWAN, CL ;
STEFFEN, RP .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (12) :2290-2297
[3]   IMPAIRMENT OF ENDOTHELIUM-DEPENDENT ARTERIAL RELAXATION BY LYSOLECITHIN IN MODIFIED LOW-DENSITY LIPOPROTEINS [J].
KUGIYAMA, K ;
KERNS, SA ;
MORRISETT, JD ;
ROBERTS, R ;
HENRY, PD .
NATURE, 1990, 344 (6262) :160-162
[4]   Studies on the applicability of alginate-entrapped naringinase for the debittering of kinnow juice [J].
Puri, M ;
Marwaha, SS ;
Kothari, RM .
ENZYME AND MICROBIAL TECHNOLOGY, 1996, 18 (04) :281-285
[5]   LYSOPHOSPHATIDYLCHOLINE - A CHEMOTACTIC FACTOR FOR HUMAN-MONOCYTES AND ITS POTENTIAL ROLE IN ATHEROGENESIS [J].
QUINN, MT ;
PARTHASARATHY, S ;
STEINBERG, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (08) :2805-2809
[6]   Lysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derived macrophages [J].
Sakai, M ;
Miyazaki, A ;
Hakamata, H ;
Sato, Y ;
Matsumura, T ;
Kobori, S ;
Shichiri, M ;
Horiuchi, S .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (04) :600-605
[7]   Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins [J].
Tew, DG ;
Southan, C ;
Rice, SQJ ;
Lawrence, GMP ;
Li, HD ;
Boyd, HF ;
Moores, K ;
Gloger, IS ;
Macphee, CH .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (04) :591-599
[8]   SB-253514 and analogues;: Novel inhibitors of lipoprotein-associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579 -: I. Fermentation of producing strain, isolation and biological activity [J].
Thirkettle, J ;
Alvarez, E ;
Boyd, H ;
Brown, M ;
Diez, E ;
Hueso, J ;
Elson, S ;
Fulston, M ;
Gershater, C ;
Morata, ML ;
Perez, P ;
Ready, S ;
Sanchez-Puelles, JM ;
Sheridan, R ;
Stefanska, A ;
Warr, S .
JOURNAL OF ANTIBIOTICS, 2000, 53 (07) :664-669